WASHINGTON, Feb 20 — Americans are paying to get a star of the psychedelic medicine movement — ketamine — shipped to them for at-home mental health treatments that are being called both a breakthrough and a gamble.
Ketamine has been available in the United States since the 1970s as an anaesthetic called a “dissociative” because of the hallucinogenic effects that have helped make it a rave culture drug. Nue Life, which launched about a year ago, is one of those firms. Its CEO Juan Pablo Cappello estimated it has served over 3,000 ketamine patients so far.
“The at-home telemedicine model, I would argue, is actually safer and more effective for patients,” allowing more patients “to actually take advantage of these therapies,” he added.